Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 53.

Journal Article

Al-Sawaf, Othman, Bahlo, Jasmin, Robrecht, Sandra, Fischer, Kirsten, Herling, Carmen D., Hoechstetter, Manuela, Fink, Anna-Maria, von Tresckow, Julia, Langerbeins, Petra, Cramer, Paula, Stilgenbauer, Stephan, Wendtner, Clemens M., Eichhorst, Barbara, Hallek, Michael and Goede, Valentin (2018). Outcome of patients aged 80 years or older treated for chronic lymphocytic leukaemia. Br. J. Haematol., 183 (5). S. 727 - 736. HOBOKEN: WILEY. ISSN 1365-2141

Al-Sawaf, Othman, Bazeos, Alexandra, Robrecht, Sandra, Bahlo, Jasmin, Gower, Craig, Fink, Anna-Maria, Tresckow, Julia, Cramer, Paula, Langerbeins, Petra, Kutsch, Nadine, Humphrey, Kathryn, Fingerle-Rowson, Guenter, Stilgenbauer, Stephan, Wendtner, Clemens-Martin, Fischer, Kirsten, Eichhorst, Barbara, Hallek, Michael and Goede, Valentin (2019). Mode of progression after first line treatment correlates with outcome of chronic lymphocytic leukemia (CLL). Am. J. Hematol., 94 (9). S. 1002 - 1007. HOBOKEN: WILEY. ISSN 1096-8652

Al-Sawaf, Othman, Cramer, Paula, Goede, Valentin, Hallek, Michael and Pflug, Natali (2017). Bendamustine and its role in the treatment of unfit patients with chronic lymphocytic leukaemia: a perspective review. Ther. Adv. Hematol., 8 (6). S. 197 - 206. LONDON: SAGE PUBLICATIONS LTD. ISSN 2040-6215

Al-Sawaf, Othman, Fischer, Kirsten, Engelke, Anja, Pflug, Natali, Hallek, Michael and Goede, Valentin (2017). Obinutuzumab in chronic lymphocytic leukemia: design, development and place in therapy. Drug Des. Dev. Ther., 11. S. 295 - 305. ALBANY: DOVE MEDICAL PRESS LTD. ISSN 1177-8881

Al-Sawaf, Othman, Robrecht, Sandra, Bahlo, Jasmin, Fink, Anna-Maria, Cramer, Paula, Maurer, Christian, Bergmann, Manuela, Dreyling, Martin, Lange, Elisabeth, Kneba, Michael, Stilgenbauer, Stephan, Jaeger, Ulrich, Wendtner, Clemens, Fischer, Kirsten, Goede, Valentin, Hallek, Michael, Eichhorst, Barbara, Hopfinger, Georg, Doehner, Hartmut and Kiehl, Michael (2017). Impact of gender on outcome after chemoimmunotherapy in patients with chronic lymphocytic leukemia: a meta-analysis of the German CLL Study Group (GCLLSG). Leuk. Lymphoma, 58. S. 62 - 64. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Al-Sawaf, Othman, Robrecht, Sandra, Bahlo, Jasmin, Fink, Anna-Maria, Cramer, Paula, von Tresckow, Julia, Lange, Elisabeth, Kiehl, Michael, Dreyling, Martin, Rittgen, Matthias, Duerig, Jan, Fischer, Kirsten, Stilgenbauer, Stephan, Wendtner, Clemens, Goede, Valentin, Hallek, Michael and Eichhorst, Barbara (2020). Richter transformation in CLL: a meta-analysis of GCLLSG trials. Leuk. Lymphoma, 61. S. 98 - 101. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Bazeos, Alexandra, Gower, Craig, Swann, Francine, Trask, Peter C., Dixon, Mark, Crompton, Noelle, Kinnersley, Nelson, Al-Sawaf, Othman, Goede, Valentin, Fingerle-Rowson, Gunter and Humphrey, Kathryn (2016). Progression By Lymphocytosis Correlates with Favourable Long-Term Clinical Outcomes in Chronic Lymphocytic Leukemia (CLL). Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Cramer, Paula, Isfort, Susanne, Bahlo, Jasmin, Stilgenbauer, Stephan, Doehner, Hartmut, Bergmann, Manuela, Stauch, Martina, Kneba, Michael, Lange, Elisabeth, Langerbeins, Petra, Pflug, Natali, Kovacs, Gabor, Goede, Valentin, Fink, Anna-Maria, Elter, Thomas, Fischer, Kirsten, Wendtner, Clemens-Martin, Hallek, Michael and Eichhorst, Barbara (2015). Outcome of advanced chronic lymphocytic leukemia following different first-line and relapse therapies: a meta-analysis of five prospective trials by the German CLL Study Group (GCLLSG). Haematologica, 100 (11). S. 1451 - 1460. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Cramer, Paula, Langerbeins, Petra, Fischer, Kirsten, Eichhorst, Barbara, Hallek, Michael and Goede, Valentin (2016). Dose-reduced fludarabine, cyclophosphamide and rituximab (FCR) in older patients with chronic lymphocytic leukemia: does one size fit all? Leuk. Lymphoma, 57 (5). S. 987 - 991. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Cremer, Birgit, Sandmaier, Brenda M., Bethge, Wolfgang, Lange, Thoralf, Goede, Valentin, Holtick, Udo, Hallek, Michael and Huebel, Kai (2011). Reduced-Intensity Conditioning in Allogeneic Stem Cell Transplantation for Hematological Malignancies: A Historical Perspective. Onkologie, 34 (12). S. 710 - 716. BASEL: KARGER. ISSN 1423-0240

Dimier, Natalie, Delmar, Paul, Ward, Carol, Morariu-Zamfir, Rodica, Fingerle-Rowson, Guenter, Bahlo, Jasmin, Fischer, Kirsten, Eichhorst, Barbara, Goede, Valentin, van Dongen, Jacques J. M., Ritgen, Matthias, Boettcher, Sebastian, Langerak, Anton W., Kneba, Michael and Hallek, Michael (2018). A model for predicting effect of treatment on progression-free survival using MRD as a surrogate end point in CLL. Blood, 131 (9). S. 955 - 963. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Dimier, Natalie, Delmar, Paul, Ward, Carol, Morariu-Zamfir, Rodica, Fingerle-Rowson, Gunter, Bahlo, Jasmin, Fischer, Kirsten, Eichhorst, Barbara F., Goede, Valentin, van Dongen, Jacques J. M., Ritgen, Matthias, Boettcher, Sebastian, Langerak, Anton W., Kneba, Michael and Hallek, Michael (2015). A Model for Predicting Effect of Treatment on Progression-Free Survival Using Minimal Residual Disease As a Surrogate Endpoint in Chronic Lymphocytic Leukemia. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Edelmann, Jennifer, Holzmann, Karlheinz, Tausch, Eugen, Saunderson, Emily A., Jebaraj, Billy M. C., Steinbrecher, Daniela, Dolnik, Anna, Blaette, Tamara J., Landau, Dan A., Saub, Jenny, Estenfelder, Sven, Ibach, Stefan, Cymbalista, Florence, Leblond, Veronique, Delmer, Alain ORCID: 0000-0002-1430-2574, Bahlo, Jasmin, Robrecht, Sandra, Fischer, Kirsten, Goede, Valentin, Bullinger, Lars, Wu, Catherine J., Mertens, Daniel ORCID: 0000-0003-0227-7188, Ficz, Gabriella, Gribben, John G., Hallek, Michael, Doehner, Hartmut and Stilgenbauer, Stephan (2020). Genomic alterations in high-risk chronic lymphocytic leukemia frequently affect cell cycle key regulators and NOTCH1-regulated transcription. Haematologica, 105 (5). S. 1379 - 1391. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Eichhorst, Barbara, Hallek, Michael and Goede, Valentin (2018). Management of unfit elderly patients with chronic lymphocytic leukemia. Eur. J. Intern. Med., 58. S. 7 - 14. AMSTERDAM: ELSEVIER SCIENCE BV. ISSN 1879-0828

Eichhorst, Barbara, Hallek, Michael and Goede, Valentin (2016). New treatment approaches in CLL: Challenges and opportunities in the elderly. J. Geriatr. Oncol., 7 (5). S. 375 - 383. AMSTERDAM: ELSEVIER SCIENCE BV. ISSN 1879-4076

Estenfelder, Sven, Tausch, Eugen, Robrecht, Sandra, Bahlo, Jasmin, Goede, Valentin, Ritgen, Matthias, van Dongen, Jacques J. M., Langerak, Anton W., Fingerle-Rowson, Gunter, Kneba, Michael, Fischer, Kirsten, Hallek, Michael, Dohner, Hartmut and Stilgenbauer, Stephan (2016). Gene Mutations and Treatment Outcome in the Context of Chlorambucil (Clb) without or with the Addition of Rituximab (R) or Obinutuzumab (GA-101, G) - Results of an Extensive Analysis of the Phase III Study CLL11 of the German CLL Study Group. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Fischer, Kirsten, Al-Sawaf, Othman, Fink, Anna-Maria, Dixon, Mark, Bahlo, Jasmin, Warburton, Simon, Kipps, Thomas J., Weinkove, Robert ORCID: 0000-0003-3645-7988, Robinson, Sue, Dreyling, Martin H., Opat, Stephen, Owen, Carolyn J., Lopez, Javier, Humphrey, Kathryn, Humerickhouse, Rod A., Tausch, Eugen, Eichhorst, Barbara, Wendtner, Clemens-M., Langerak, Anton W., van Dongen, Jacques J. M., Ritgen, Matthias, Boettcher, Sebastian, Stilgenbauer, Stephan, Goede, Valentin, Mobasher, Mehrdad and Hallek, Michael (2016). Safety and Efficacy of Venetoclax and Obinutuzumab in Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL) and Coexisting Medical Conditions: Final Results of the Run-in Phase of the Randomized CLL14 Trial (BO25323). Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Fischer, Kirsten, Al-Sawaf, Othman, Fink, Anna-Maria, Dixon, Mark, Bahlo, Jasmin, Warburton, Simon, Kipps, Thomas J., Weinkove, Robert ORCID: 0000-0003-3645-7988, Robinson, Sue, Seiler, Till, Opat, Stephen, Owen, Carolyn, Lopez, Javier, Humphrey, Kathryn, Humerickhouse, Rod, Tausch, Eugen, Frenzel, Lukas, Eichhorst, Barbara, Wendtner, Clemens-M., Stilgenbauer, Stephan, Langerak, Anton W., van Dongen, Jacque J. M., Boettcher, Sebastian, Ritgen, Matthias, Goede, Valentin, Mobasher, Mehrdad and Hallek, Michael (2017). Venetoclax and obinutuzumab in chronic lymphocytic leukemia. Blood, 129 (19). S. 2702 - 2706. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Fischer, Kirsten, Bahlo, Jasmin, Fink, Anna Maria, Goede, Valentin, Herling, Carmen Diana, Cramer, Paula, Langerbeins, Petra, von Tresckow, Julia, Engelke, Anja, Maurer, Christian, Kovacs, Gabor, Herling, Marco, Tausch, Eugen, Kreuzer, Karl-Anton, Eichhorst, Barbara, Boettcher, Sebastian, Seymour, John F., Ghia, Paolo ORCID: 0000-0003-3750-7342, Marlton, Paula, Kneba, Michael, Wendtner, Clemens-Martin, Doehner, Hartmut, Stilgenbauer, Stephan and Hallek, Michael (2016). Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial. Blood, 127 (2). S. 208 - 216. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Fischer, Kirsten, Cramer, Paula, Busch, Raymonde, Boettcher, Sebastian, Bahlo, Jasmin, Schubert, Joeerg, Pflueger, Karl H., Schott, Silke, Goede, Valentin, Isfort, Susanne, von Tresckow, Julia, Fink, Anna-Maria, Buehler, Andreas, Winkler, Dirk, Kreuzer, Karl-Anton, Staib, Peter, Ritgen, Matthias, Kneba, Michael, Doehner, Hartmut, Eichhorst, Barbara F., Hallek, Michael, Stilgenbauer, Stephan and Wendtner, Clemens-Martin (2012). Bendamustine in Combination With Rituximab for Previously Untreated Patients With Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group. J. Clin. Oncol., 30 (26). S. 3209 - 3217. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Fischer, Kirsten, Cramer, Paula, Busch, Raymonde, Stilgenbauer, Stephan, Bahlo, Jasmin, Schweighofer, Carmen D., Boettcher, Sebastian, Staib, Peter, Kiehl, Michael, Eckart, Michael J., Kranz, Gabriele, Goede, Valentin, Elter, Thomas, Buehler, Andreas, Winkler, Dirk, Kneba, Michael, Doehner, Hartmut, Eichhorst, Barbara F., Hallek, Michael and Wendtner, Clemens-Martin (2011). Bendamustine Combined With Rituximab in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group. J. Clin. Oncol., 29 (26). S. 3559 - 3567. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Fischer, Kirsten, Fink, Anna-Maria, Bishop, Helen, Dixon, Mark, Bahlo, Jasmin, Chol, Michael Y., Weinkove, Robert ORCID: 0000-0003-3645-7988, Robinson, Sue, Dreyling, Martin, Seiler, Till, Opat, Stephen, Owen, Carolyn, Lopez, Javier, Sr., Kutsch, Nadine, Tausch, Eugen, Ritgen, Matthias, Humerickhouse, Rod A., Humphrey, Kathryn, Wenger, Michael K., Goede, Valentin, Eichhorst, Barbara, Wendtner, Clemens-Martin, Stilgenbauer, Stephan, Kipps, Thomas J. and Hallek, Michael (2015). Results of the Safety Run-in Phase of CLL14 (BO25323): A Prospective, Open-Label, Multicenter Randomized Phase Ill Trial to Compare the Efficacy and Safety of Obinutuzumab and Venetoclax (GDC-0199/ABT-199) with Obinutuzumab and Chlorambucil in Patients with Previously Untreated CLL and Coexisting Medical Conditions. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Freeman, Ciara Louise, Dixon, Mark, Houghton, Richard, Humphrey, Kathryn, Fingerle-Rowson, Gunter, Kreuzer, Karl-Anton, Engelke, Anja, Hallek, Michael and Goede, Valentin (2014). Risk Factors Associated with the Development of Infusion-Related Reactions in Patients with Chronic Lymphocytic Leukaemia Treated with Anti-CD20 Monoclonal Antibodies: Analysis of the CLL11 Study Dataset. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Fuerstenau, Moritz, Hopfinger, Georg, Robrecht, Sandra, Fink, Anna-Maria, Al-Sawaf, Othman, Langerbeins, Petra, Cramer, Paula, Von Tresckow, Julia, Maurer, Christian, Kutsch, Nadine, Hoechstetter, Manuela, Dreyling, Martin, Lange, Elisabeth, Kneba, Michael, Stilgenbauer, Stephan, Doehner, Hartmut, Hensel, Manfred, Kiehl, Michael G., Jaeger, Ulrich, Wendtner, Clemens-Martin, Goede, Valentin, Fischer, Kirsten, von Bergwelt-Baildon, Michael, Eichhorst, Barbara, Hallek, Michael and Theurich, Sebastian ORCID: 0000-0001-5706-8258 (2020). Influence of obesity and gender on treatment outcomes in patients with chronic lymphocytic leukemia (CLL) undergoing rituximab-based chemoimmunotherapy. Leukemia, 34 (4). S. 1177 - 1182. LONDON: SPRINGERNATURE. ISSN 1476-5551

Fuerstenau, Moritz, Hopfinger, Georg, Robrecht, Sandra, Fink, Anna-Maria, Al-Sawaf, Othman, Langerbeins, Petra, Cramer, Paula, Von Tresckow, Julia, Maurer, Christian, Kutsch, Nadine, Hoechstetter, Manuela, Dreyling, Martin, Lange, Elisabeth, Kneba, Michael, Stilgenbauer, Stephan, Doehner, Hartmut, Hensel, Manfred, Kiehl, Michael G., Jaeger, Ulrich, Wendtner, Clemens-Martin, Goede, Valentin, Fischer, Kirsten, Hallek, Michael, Eichhorst, Barbara and Theurich, Sebastian (2018). Obesity Negatively Impacts Outcome in Female Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Fludarabine, Cyclophosphamide and Rituximab (FCR): An Analysis of Three Phase III Studies of the German CLL Study Group (GCLLSG). Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Furstenau, Moritz, Bahlo, Jasmin, Fink, Anna-Maria, Lange, Elisabeth, Dreger, Peter, Dreyling, Martin, Hess, Georg, Ritgen, Matthias, Kneba, Michael, Doehner, Hartmut, Stilgenbauer, Stephan, Wendtner, Clemens-Martin, Goede, Valentin, Fischer, Kirsten, Boettcher, Sebastian, Hallek, Michael and Eichhorst, Barbara (2018). Residual Abdominal Lymphadenopathy after Intensive Frontline Chemoimmunotherapy Is Associated with Inferior Outcome Regardless of MRD Status in Advanced Chronic Lymphocytic Leukemia (CLL). Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Goede, Valentin (2017). Marginal zone lymphoma in elderly and geriatric patients. Best Pract. Res. Clin. Haematol., 30 (1-2). S. 158 - 166. OXFORD: ELSEVIER SCI LTD. ISSN 1532-1924

Goede, Valentin, Bahlo, Jasmin, Chataline, Viktoria, Eichhorst, Barbara, Duerig, Jan, Stilgenbauer, Stephan, Kolb, Gerald, Honecker, Friedemann, Wedding, Ulrich and Hallek, Michael (2016). Evaluation of geriatric assessment in patients with chronic lymphocytic leukemia: Results of the CLL9 trial of the German CLL study group. Leuk. Lymphoma, 57 (4). S. 789 - 797. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Goede, Valentin, Bahlo, Jasmin, Kutsch, Nadine, Fischer, Kirsten, Fink, Anna Maria, Fingerle-Rowson, Guenter, Stilgenbauer, Stephan, Bergmann, Manuela A., Eichhorst, Barbara F. and Hallek, Michael (2016). Evaluation of the International Prognostic Index for Chronic Lymphocytic Leukemia (CLL-IPI) in Elderly Patients with Comorbidities: Analysis of the CLL11 Study Population. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Goede, Valentin, Bahlo, Jasmin, Robrecht, Sandra, Al-Sawaf, Othman, Fink, Anna-Maria, Stilgenbauer, Stephan, Fischer, Kirsten, Eichhorst, Barbara, Hallek, Michael and Wendtner, Clemens (2017). Cumulative Illness Rating Scale (CIRS) provides prognostic information beyond the International Prognostic Index for chronic lymphocytic leukemia (CLL-IPI): analysis of 3 randomized trials of the German CLL Study Group. Leuk. Lymphoma, 58. S. 96 - 99. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Goede, Valentin, Busch, Raymonde, Bahlo, Jasmin, Chataline, Viktoria, Kremers, Stephan, Mueller, Lothar, Reschke, Daniel, Schlag, Rudolf, Schmidt, Burkhard, Vehling-Kaiser, Ursula, Wedding, Ulrich, Stilgenbauer, Stefan and Hallek, Michael (2016). Low-dose fludarabine with or without darbepoetin alfa in patients with chronic lymphocytic leukemia and comorbidity: primary results of the CLL9 trial of the German CLL Study Group. Leuk. Lymphoma, 57 (3). S. 596 - 604. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Goede, Valentin, Cramer, Paula, Busch, Raymonde, Bergmann, Manuela, Stauch, Martina, Hopfinger, Georg, Stilgenbauer, Stephan, Doehner, Hartmut, Westermann, Anne, Wendtner, Clemens M., Eichhorst, Barbara and Hallek, Michael (2014). Interactions between comorbidity and treatment of chronic lymphocytic leukemia: results of German Chronic Lymphocytic Leukemia Study Group trials. Haematologica, 99 (6). S. 1095 - 1101. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Goede, Valentin, Engelke, Anja, Fischer, Kirsten, Lopez Jimenez, Javier, Kuzmin, Alexej, Dyer, Martin J. S., Le Du, Katell, Liberati, Anna Marina, Schlag, Rudolf, Langerak, Anton W., Ritgen, Matthias, Stilgenbauer, Stephan, Asikanius, Elina, Humphrey, Kathryn, Wenger, Michael K., Fingerle-Rowson, Guenter and Hallek, Michael (2014). Salvage Therapy with Obinutuzumab (GA101) Plus Chlorambucil (Clb) after Treatment Failure of Clb Alone in Patients with Chronic Lymphocytic Leukemia (CLL) and Comorbidities: Results of the CLL11 Study. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Goede, Valentin, Fischer, Kirsten, Bosch, Francesc ORCID: 0000-0001-9241-2886, Follows, George, Frederiksen, Henrik ORCID: 0000-0001-8905-0220, Cuneo, Antonio, Ludwig, Heinz, Crompton, Noelle, Maurer, Joerg, Uguen, Marianne, Fingerle-Rowson, Gunter and Hallek, Michael (2015). Updated Survival Analysis from the CLL11 Study: Obinutuzumab Versus Rituximab in Chemoimmunotherapy-Treated Patients with Chronic Lymphocytic Leukemia. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Goede, Valentin, Fischer, Kirsten, Busch, Raymonde, Engelke, Anja, Eichhorst, Barbara, Wendtner, Clemens M., Chagorova, Tatiana, de la Serna, Javier, Dilhuydy, Marie-Sarah, Illmer, Thomas, Opat, Stephen, Owen, Carolyn J., Samoylova, Olga, Kreuzer, Karl-Anton, Stilgenbauer, Stephan, Doehner, Hartmut, Langerak, Anton W., Ritgen, Matthias, Kneba, Michael, Asikanius, Elina, Humphrey, Kathryn, Wenger, Michael and Hallek, Michael (2014). Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions. N. Engl. J. Med., 370 (12). S. 1101 - 1111. WALTHAM: MASSACHUSETTS MEDICAL SOC. ISSN 1533-4406

Goede, Valentin, Fischer, Kirsten and Hallek, Michael (2014). Chemoimmunotherapy for Chronic Lymphocytic Leukemia REPLY. N. Engl. J. Med., 370 (24). S. 2348 - 2350. WALTHAM: MASSACHUSETTS MEDICAL SOC. ISSN 1533-4406

Goede, Valentin, Fischer, Kirsten, Raymonde, Busch, Ulrich, Jaeger, Dilhuydy, Marie-Sarah, Wickham, Nicholas, De Guibert, Sophie, Fink, Anna Maria, Hagist, Susanne, Pflug, Natali, Bahlo, Jasmin, Kranz, Gabriele, Bieska, Gabriel, Humphrey, Kathryn, Bishop, Helen, Wenger, Michael and Hallek, Michael (2010). Chemoimmunotherapy with Chlorambucil and the Type II CD20-Antibody GA101 In Patients with Chronic Lymphocytic Leukemia and Comorbidity: Results of the Run-In Phase of the CLL11 (BO21004) Trial. Blood, 116 (21). S. 597 - 598. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Goede, Valentin and Hallek, Michael (2015). Pharmacotherapeutic Management of Chronic Lymphocytic Leukaemia in Patients with Comorbidities: New Agents, New Hope. Drugs Aging, 32 (11). S. 877 - 887. NORTHCOTE: ADIS INT LTD. ISSN 1179-1969

Goede, Valentin and Hallek, Michael (2018). Which haemato-oncological Drugs are dispensable or unsuitable in Old Age? Dtsch. Med. Wochenschr., 143 (4). S. 244 - 253. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-4413

Goede, Valentin, Klein, Christian ORCID: 0000-0001-7594-7280 and Stilgenbauer, Stephan (2015). Obinutuzumab (GA101) for the Treatment of Chronic Lymphocytic Leukemia and Other B-Cell Non-Hodgkin's Lymphomas: A Glycoengineered Type II CD20 Antibody. Oncol. Res. Treat., 38 (4). S. 185 - 193. BASEL: KARGER. ISSN 2296-5262

Goede, Valentin, Klein, Christian ORCID: 0000-0001-7594-7280 and Stilgenbauer, Stephan (2015). Obinutuzumab (GA101) for the Treatment of Chronic Lymphocytic Leukemia and Other B-Cell Non-Hodgkin's Lymphomas: A Glycoengineered Type II CD20 Antibody. Oncol. Res. Treat., 38 (4). S. 185 - 193. BASEL: KARGER. ISSN 2296-5262

Goede, Valentin and Schulz, Ralf-Joachim (2015). Geriatric assessment in older adults with aggressive lymphoma: growing evidence and new emerging questions. Leuk. Lymphoma, 56 (4). S. 835 - 837. LONDON: INFORMA HEALTHCARE. ISSN 1029-2403

Goede, Valentin and Schulz, Ralf-Joachim (2015). Geriatric assessment in older adults with aggressive lymphoma: growing evidence and new emerging questions. Leuk. Lymphoma, 56 (4). S. 835 - 837. LONDON: INFORMA HEALTHCARE. ISSN 1029-2403

Hacker, Ulrich T., Escalona-Espinosa, Laura, Consalvo, Nicola, Goede, Valentin, Schiffmann, Lars, Scherer, Stefan J., Hedge, Priti, Van Cutsem, Eric, Coutelle, Oliver and Buening, Hildegard (2016). Evaluation of Angiopoietin-2 as a biomarker in gastric cancer: results from the randomised phase III AVAGAST trial. Br. J. Cancer, 114 (8). S. 855 - 863. LONDON: NATURE PUBLISHING GROUP. ISSN 1532-1827

Herling, Carmen Diana, Klaumuenzer, Marion, Rocha, Cristiano Krings, Altmueller, Janine, Thiele, Holger, Bahlo, Jasmin, Kluth, Sandra, Crispatzu, Giuliano, Herling, Marco, Schiller, Joanna, Engelke, Anja, Tausch, Eugen, Doehner, Hartmut, Fischer, Kirsten, Goede, Valentin, Nuernberg, Peter, Reinhardt, Hans Christian, Stilgenbauer, Stephan, Hallek, Michael and Kreuzer, Karl-Anton (2016). Complex karyotypes and KRAS and POT1 mutations impact outcome in CLL after chlorambucil-based chemotherapy or chemoimmunotherapy. Blood, 128 (3). S. 395 - 405. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Jaramillo, Sonia, Agathangelidis, Andreas, Schneider, Christof, Bahlo, Jasmin, Robrecht, Sandra, Tausch, Eugen, Bloehdorn, Johannes, Hoechstetter, Manuela, Fischer, Kirsten, Eichhorst, Barbara, Goede, Valentin, Hallek, Michael, Doehner, Hartmut, Rosenquist, Richard, Ghia, Paolo, Stamatopoulos, Kostas and Stilgenbauer, Stephan (2020). Prognostic impact of prevalent chronic lymphocytic leukemia stereotyped subsets: analysis within prospective clinical trials of the German CLL Study Group. Haematologica, 105 (11). S. 2598 - 2608. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Klanova, Magdalena, Oestergaard, Mikkel Z., Trneny, Marek, Hiddemann, Wolfgang, Marcus, Robert, Sehn, Laurie H., Vitolo, Umberto, Bazeos, Alexandra, Goede, Valentin, Zeuner, Harald, Knapp, Andrea, Sahin, Deniz, Spielewoy, Nathalie, Bolen, Christopher R., Cardona, Andres ORCID: 0000-0002-3873-0194, Klein, Christian, Venstrom, Jeffrey M., Nielsen, Tina and Fingerle-Rowson, Guenter (2019). Prognostic Impact of Natural Killer Cell Count in Follicular Lymphoma and Diffuse Large B-cell Lymphoma Patients Treated with Immunochemotherapy. Clin. Cancer Res., 25 (15). S. 4634 - 4644. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1557-3265

Kovacs, Gabor, Bahlo, Jasmin, Kluth, Sandra, Cramer, Paula, Fink, Anna-Maria, Fischer, Kirsten, Gross-Ophoff-Mueller, Carolin, Langerbeins, Petra, Maurer, Christian, von Tresckow, Julia, Wendtner, Clemens-Martin, Stilgenbauer, Stephan, Hallek, Michael, Eichhorst, Barbara and Goede, Valentin (2015). Prognostic Impact and Risk Factors of Reducing Prescribed Doses of Fludarabine, Cyclophosphamide and Rituximab (FCR) during Frontline Treatment of Chronic Lymphocytic Leukemia (CLL). Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Langerak, Anton W., Ritgen, Matthias, Goede, Valentin, Robrecht, Sandra, Bahlo, Jasmin, Fischer, Kirsten, Steurer, Michael, Trneny, Marek, Mulligan, Stephen P., Mey, Ulrich J. M., Trunzer, Kerstin, Fingerle-Rowson, Guenter, Humphrey, Kathryn, Stilgenbauer, Stephan, Boettcher, Sebastian, Brueggemann, Monika, Hallek, Michael, Kneba, Michael and van Dongen, Jacques J. M. (2019). Prognostic value of MRD in CLL patients with comorbidities receiving chlorambucil plus obinutuzumab or rituximab. Blood, 133 (5). S. 494 - 498. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Segura, Sonia Jaramillo, Agathangelidis, Andreas, Schneider, Christof, Bahlo, Jasmin, Robrecht, Sandra, Tausch, Eugen, Bloehdorn, Johannes, Hoechstetter, Manuela, Fischer, Kirsten, Eichhorst, Barbara, Goede, Valentin, Hallek, Michael, Doehner, Hartmut, Brandell, Richard Rosenquist, Ghia, Paolo, Stamatopoulos, Kostas and Stilgenbauer, Stephan (2020). Prognostic impact of common chronic lymphocytic leukemia stereotyped subsets: analysis within prospective clinical trials of the German CLL Study Group (GCLLSG). Leuk. Lymphoma, 61. S. 135 - 137. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Shanafelt, Tait D., Parikh, Sameer A., Noseworthy, Peter A., Goede, Valentin, Chaffee, Kari G., Bahlo, Jasmin, Call, Timothy G., Schwager, Susan M., Ding, Wei, Eichhorst, Barbara, Fischer, Kirsten, Leis, Jose F., Chanan-Khan, Asher Alban, Hallek, Michael, Slager, Susan L. and Kay, Neil E. (2017). Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL). Leuk. Lymphoma, 58 (7). S. 1630 - 1640. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Simon, Florian, Giza, Adam, Robrecht, Sandra, Fink, Anna-Maria, Cramer, Paula ORCID: 0000-0003-4046-9922, von Tresckow, Julia, Fuerstenau, Moritz, Goede, Valentin, Tausch, Eugen, Schneider, Christof, Stilgenbauer, Stephan, Wendtner, Clemens-Martin, Eichhorst, Barbara, Fischer, Kirsten, Hallek, Michael ORCID: 0000-0002-7425-4455 and Al-Sawaf, Othman (2022). Pooled analysis of first-line treatment with targeted agents in patients with chronic lymphocytic leukemia aged 80 years and older. Leuk. Lymphoma, 63 (14). S. 3299 - 3307. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Stadler, Nicolas ORCID: 0000-0001-8212-7459, Shang, Aijing, Bosch, Francesc ORCID: 0000-0001-9241-2886, Briggs, Andrew ORCID: 0000-0002-0777-1997, Goede, Valentin, Berthier, Aurelien, Renaudin, Corinne and Leblond, Veronique (2016). A Systematic Review and Network Meta-Analysis to Evaluate the Comparative Efficacy of Interventions for Unfit Patients with Chronic Lymphocytic Leukemia. Adv. Ther., 33 (10). S. 1814 - 1831. NEW YORK: SPRINGER. ISSN 1865-8652

This list was generated on Fri Mar 29 01:06:00 2024 CET.